CD36 and COVID-19: Thus, a change in the CD36 gene expression can be associated with the unfavorable course of the disease in patients with a critical form of COVID-19 through at least two different mechanisms: activation of innate immunity to virus-containing cells and through activation of the atherogenesis processes via enhanced absorption of fatty acids and oxidized lipoproteins.